Literature DB >> 19474829

Opinion: Ocular features aid the diagnosis of Alport syndrome.

Judy Savige1, Deb Colville.   

Abstract

Alport syndrome is a common cause of inherited kidney failure but often goes unrecognized. Most affected families show an X-linked pattern of inheritance where affected males develop renal failure and hearing loss, and often lenticonus and retinopathy. Lenticonus is evident on both ophthalmoscopy and slit-lamp examination but retinal abnormalities are more obvious on imaging. Such abnormalities include a perimacular dot-and-fleck retinopathy and a peripheral fleck retinopathy, which might occur independently of each other; a 'dull macular reflex' or 'lozenge', when the perimacular flecks are confluent; and, rarely, a macular hole caused by retinal thinning. Imaging of the central and peripheral retina including 'red-free' views is a rapid, noninvasive and inexpensive test that might aid the diagnosis of Alport syndrome, particularly in male individuals with early-onset renal failure. The assistance of an interested ophthalmologist is invaluable in the diagnosis of Alport syndrome.

Entities:  

Mesh:

Year:  2009        PMID: 19474829     DOI: 10.1038/nrneph.2009.65

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN: 1759-5061            Impact factor:   28.314


  38 in total

1.  Ocular clues to the nature of disease causing end-stage renal failure.

Authors:  D Colville; H Dagher; P Miach; J Savige
Journal:  Nephrol Dial Transplant       Date:  2000-03       Impact factor: 5.992

2.  Ocular abnormalities in thin basement membrane disease.

Authors:  D Colville; J Savige; P Branley; D Wilson
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

3.  The use of ocular abnormalities to diagnose X-linked Alport syndrome in children.

Authors:  Ke Wei Zhang; Deb Colville; Rachel Tan; Colin Jones; Stephen I Alexander; Jeffrey Fletcher; Judy Savige
Journal:  Pediatr Nephrol       Date:  2008-03-15       Impact factor: 3.714

4.  Posterior polymorphous dystrophy and Alport syndrome.

Authors:  C Teekhasaenee; S Nimmanit; S Wutthiphan; K Vareesangthip; T Laohapand; P Malasitr; R Ritch
Journal:  Ophthalmology       Date:  1991-08       Impact factor: 12.079

5.  Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.

Authors:  K Yoshioka; S Hino; T Takemura; S Maki; J Wieslander; Y Takekoshi; H Makino; M Kagawa; Y Sado; C E Kashtan
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

6.  Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counselling.

Authors:  Oliver Gross; Kai-Olaf Netzer; Romy Lambrecht; Stefan Seibold; Manfred Weber
Journal:  Nephrol Dial Transplant       Date:  2002-07       Impact factor: 5.992

7.  Ocular manifestations of Alport's syndrome: a hereditary disorder of basement membranes?

Authors:  J A Govan
Journal:  Br J Ophthalmol       Date:  1983-08       Impact factor: 4.638

8.  Genetic testing for X-linked Alport syndrome by direct sequencing of COL4A5 cDNA from hair root RNA samples.

Authors:  Bárbara Tazón-Vega; Elisabet Ars; Moisès Burset; Sheila Santín; Patricia Ruíz; Patricia Fernández-Llama; José Ballarín; Roser Torra
Journal:  Am J Kidney Dis       Date:  2007-08       Impact factor: 8.860

9.  The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure.

Authors:  D Colville; Y Y Wang; R Tan; J Savige
Journal:  Br J Ophthalmol       Date:  2008-11-19       Impact factor: 4.638

10.  [Considerations on the pathogenesis of the cochleo-renal syndrome (author's transl)].

Authors:  W Arnold
Journal:  Acta Otolaryngol       Date:  1980 Mar-Apr       Impact factor: 1.494

View more
  10 in total

Review 1.  Ocular features in Alport syndrome: pathogenesis and clinical significance.

Authors:  Judy Savige; Shivanand Sheth; Anita Leys; Anjali Nicholson; Heather G Mack; Deb Colville
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-03       Impact factor: 8.237

2.  [Hereditary sensorineural hearing impairment and macrothrombocytopenia: a rare MYH9 gene mutation].

Authors:  A Böttcher; R Knecht; C-J Busch; B B Lörincz; C V Dalchow
Journal:  HNO       Date:  2013-02       Impact factor: 1.284

3.  Simultaneous Bilateral Anterior and Posterior Lenticonus in Alport Syndrome.

Authors:  Ravi Kant Bamotra; Prem Chandra Kesarwani; Shazia Qayum
Journal:  J Clin Diagn Res       Date:  2017-08-01

4.  [Bilateral visual loss in a young male patient].

Authors:  N Terai; F Raiskup
Journal:  Ophthalmologe       Date:  2012-05       Impact factor: 1.059

5.  Temporal retinal thinning might be an early diagnostic indicator in male pediatric X-linked Alport syndrome.

Authors:  Rui-Lin Zhu; Liang Zhao; Xiao-Peng Gu; Ya-Di Zhang; Fang Wang; Yan-Qin Zhang; Liu Yang
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

6.  Spontaneous Anterior Lens Capsule Rupture Of a Patient with Alport Syndrome - A Case Report.

Authors:  Kalina Trifonova; George Jordanoff; Valentin Stoyanov; Kiril Slaveykov
Journal:  Open Access Maced J Med Sci       Date:  2017-12-11

Review 7.  Basement Membrane Defects in Genetic Kidney Diseases.

Authors:  Christine Chew; Rachel Lennon
Journal:  Front Pediatr       Date:  2018-01-29       Impact factor: 3.418

Review 8.  How benign is hematuria? Using genetics to predict prognosis.

Authors:  Daniel P Gale
Journal:  Pediatr Nephrol       Date:  2013-01-17       Impact factor: 3.714

9.  A novel splice site mutation in the COL4A5 gene in a Chinese female patient with rare ocular abnormalities.

Authors:  Chan Zhao; Fang Wang; Yanqin Zhang; Yubing Wen; Ying Su; Chengfen Zhang; Ruifang Sui; Fei Xu; Jie Ding; Fangtian Dong
Journal:  Mol Vis       Date:  2012-08-08       Impact factor: 2.367

10.  Increased Subfoveal Choroidal Thickness and Retinal Structure Changes on Optical Coherence Tomography in Pediatric Alport Syndrome Patients.

Authors:  Seda Karaca Adıyeke; Gamze Ture; Fatma Mutlubaş; Hasan Aytoğan; Onur Vural; Neslisah Kutlu Uzakgider; Gulsah Talay Dayangaç; Ekrem Talay
Journal:  J Ophthalmol       Date:  2019-01-21       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.